Large-scale testing (Phase 3)Study completedNCT04922788
What this trial is testing
Study to Evaluate the Safety, Immunogenicity, and Efficacy of Nanocovax Vaccine Against COVID-19
Who this might be right for
SARS-CoV-2 InfectionCOVID-19
Nanogen Pharmaceutical Biotechnology Joint Stock Company 13,006